Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Retatrutide is an investigational medication not approved by the FDA for routine clinical use
The KLOW stack peptide combines GHK-Cu (glycyl-L-histidyl-L-lysine copper complex, 50mg), BPC-157 (body protection compound 15-mer, 10mg), TB-500 (synthetic Thymosin Beta-4 analogue, 10mg), and KPV (Lys-Pro-Val C-terminal alpha-MSH tripeptide, 10mg) in a single co-lyophilized 80mg vial
Advantages of metformin include the longstanding research supporting its efficacy and safety, an expected decrease in the glycated hemoglobin (HbA1c) level of 1% to 1.5%, low cost, minimal hypoglycemic risk, and potential reductions in cardiovascular (CV) events due to decreased low-density lipoprotein (LDL) cholesterol
IV treatments may show visible improvements in 24 weeks
Frontiers in Oncology , 15 , 1582116 Ansari, R
